Cannabis use disorder (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cannabis use disorder" in English language version.

refsWebsite

Global rank English rank

71nih.gov

4^th place

45doi.org

2^nd place

17worldcat.org

5^th place

10semanticscholar.org

11^th place

8^th place

6web.archive.org

1^st place

3drugabuse.gov

6,166^th place

5,476^th place

2harvard.edu

18^th place

17^th place

2who.int

195^th place

302^nd place

1zenodo.org

621^st place

380^th place

1nytimes.com

7^th place

1books.google.com

3^rd place

1sciencedirect.com

149^th place

178^th place

1psychiatrist.com

low place

1ucl.ac.uk

1,306^th place

885^th place

1jaacap.org

low place

1gouv.qc.ca

1,004^th place

1,546^th place

1dsm5.org

low place

1rogershospital.org

low place

1ahrq.gov

9,469^th place

6,259^th place

1unifi.it

low place

1nice.org.uk

3,258^th place

2,666^th place

1unodc.org

2,494^th place

2,269^th place

1pewresearch.org

1,418^th place

966^th place

1samhsa.gov

low place

1adf.org.au

low place

1europa.eu

68^th place

117^th place

1espad.org

low place

adf.org.au

druginfo.adf.org.au

"Drug Info". Australian Drug Foundation. Archived from the original on 25 April 2011.

ahrq.gov

innovations.ahrq.gov

"With Support From Collaborative, Primary Care Practices Identify and Address Behavioral Health Issues, Reducing Binge Drinking, Marijuana Use, and Depression Symptoms". Agency for Healthcare Research and Quality. 8 May 2013. Retrieved 10 May 2013.

books.google.com

Clinical Textbook of Addictive Disorders, Marijuana, David McDowell, page 169, Published by Guilford Press, 2005 ISBN 1-59385-174-X.

doi.org

Jacobus, Joanna; Goldenberg, Diane; Wierenga, Christina E.; Tolentino, Neil J.; Liu, Thomas T.; Tapert, Susan F. (1 August 2012). "Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users". Psychopharmacology. 222 (4): 675–684. doi:10.1007/s00213-012-2674-4. ISSN 1432-2072. PMC 3510003. PMID 22395430.
Gordon AJ, Conley JW, Gordon JM (December 2013). "Medical consequences of marijuana use: a review of current literature". Current Psychiatry Reports (Review). 15 (12): 419. doi:10.1007/s11920-013-0419-7. PMID 24234874. S2CID 29063282.
Nielsen S, Gowing L, Sabioni P, Le Foll B (January 2019). "Pharmacotherapies for cannabis dependence". The Cochrane Database of Systematic Reviews. 1 (3): CD008940. doi:10.1002/14651858.CD008940.pub3. PMC 6360924. PMID 30687936.
Danovitch I, Gorelick DA (June 2012). "State of the art treatments for cannabis dependence". The Psychiatric Clinics of North America (Review). 35 (2): 309–26. doi:10.1016/j.psc.2012.03.003. PMC 3371269. PMID 22640758.
Dervaux A, Laqueille X (December 2012). "[Cannabis: Use and dependence]". Presse Médicale (in French). 41 (12 Pt 1): 1233–40. doi:10.1016/j.lpm.2012.07.016. PMID 23040955.
Hirvonen J, Goodwin RS, Li CT, Terry GE, Zoghbi SS, Morse C, et al. (June 2012). "Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers". Molecular Psychiatry. 17 (6): 642–9. doi:10.1038/mp.2011.82. PMC 3223558. PMID 21747398.
Madras BK (August 2014). "Dopamine challenge reveals neuroadaptive changes in marijuana abusers". Proceedings of the National Academy of Sciences of the United States of America. 111 (33): 11915–6. Bibcode:2014PNAS..11111915M. doi:10.1073/pnas.1412314111. PMC 4143049. PMID 25114244.
González S, Cebeira M, Fernández-Ruiz J (June 2005). "Cannabinoid tolerance and dependence: a review of studies in laboratory animals". Pharmacology, Biochemistry, and Behavior. 81 (2): 300–18. doi:10.1016/j.pbb.2005.01.028. PMID 15919107. S2CID 23328509.
Maldonado R, Berrendero F, Ozaita A, Robledo P (May 2011). "Neurochemical basis of cannabis addiction". Neuroscience. 181: 1–17. doi:10.1016/j.neuroscience.2011.02.035. PMID 21334423. S2CID 6660057.
Wilkie G, Sakr B, Rizack T (May 2016). "Medical Marijuana Use in Oncology: A Review". JAMA Oncology. 2 (5): 670–675. doi:10.1001/jamaoncol.2016.0155. PMID 26986677.
Budney AJ, Roffman R, Stephens RS, Walker D (December 2007). "Marijuana dependence and its treatment". Addiction Science & Clinical Practice. 4 (1): 4–16. doi:10.1151/ascp07414 (inactive 15 April 2025). PMC 2797098. PMID 18292704.{{cite journal}}: CS1 maint: DOI inactive as of April 2025 (link)
Borgelt LM, Franson KL, Nussbaum AM, Wang GS (February 2013). "The pharmacologic and clinical effects of medical cannabis". Pharmacotherapy (Review). 33 (2): 195–209. doi:10.1002/phar.1187. PMID 23386598. S2CID 8503107.
Bahji, Anees; Stephenson, Callum; Tyo, Richard; Hawken, Emily R.; Seitz, Dallas P. (9 April 2020). "Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids". JAMA Network Open. 3 (4): e202370. doi:10.1001/jamanetworkopen.2020.2370. PMC 7146100. PMID 32271390.
Livne O, Shmulewitz D, Lev-Ran S, Hasin DS (February 2019). "DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults". Drug and Alcohol Dependence. 195: 170–177. doi:10.1016/j.drugalcdep.2018.09.005. PMC 6359953. PMID 30361043.
Allsop, David (2011). "The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress". Drug and Alcohol Dependence. 119 (1–2): 123–129. doi:10.1016/j.drugalcdep.2011.06.003. PMID 21724338. Retrieved 12 March 2024.
Cougle, Jesse R.; Hakes, Jahn K.; Macatee, Richard J.; Zvolensky, Michael J.; Chavarria, Jesus (27 April 2016). "Probability and Correlates of Dependence Among Regular Users of Alcohol, Nicotine, Cannabis, and Cocaine: Concurrent and Prospective Analyses of the National Epidemiologic Survey on Alcohol and Related Conditions". The Journal of Clinical Psychiatry. 77 (4): e444 – e450. doi:10.4088/JCP.14m09469. PMID 27137428.
Connor, Jason P.; Stjepanović, Daniel; Le Foll, Bernard; Hoch, Eva; Budney, Alan J.; Hall, Wayne D. (25 February 2021). "Cannabis use and cannabis use disorder". Nature Reviews Disease Primers. 7 (1): 3. doi:10.1038/s41572-021-00247-4. ISSN 2056-676X. PMC 8655458. PMID 33627670.
Gorelick, David A. (14 December 2023). "Cannabis-Related Disorders and Toxic Effects". New England Journal of Medicine. 389 (24): 2267–2275. doi:10.1056/NEJMra2212152. PMID 38091532.
Volkow, Nora D.; Swanson, James M.; Evins, A. Eden; DeLisi, Lynn E.; Meier, Madeline H.; Gonzalez, Raul; Bloomfield, Michael A. P.; Curran, H. Valerie; Baler, Ruben (1 March 2016). "Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review" (PDF). JAMA Psychiatry. 73 (3): 292–7. doi:10.1001/jamapsychiatry.2015.3278. ISSN 2168-622X. PMID 26842658.
Levine, Amir; Clemenza, Kelly; Rynn, Moira; Lieberman, Jeffrey (1 March 2017). "Evidence for the Risks and Consequences of Adolescent Cannabis Exposure". Journal of the American Academy of Child & Adolescent Psychiatry. 56 (3): 214–225. doi:10.1016/j.jaac.2016.12.014. ISSN 0890-8567. PMID 28219487.
Oladunjoye, Adeolu Funso; Li, Elijah; Aneni, Kammarauche; Onigu-Otite, Edore (2023). "Cannabis use disorder, suicide attempts, and self-harm among adolescents: A national inpatient study across the United States". PLOS ONE. 18 (10): e0292922. Bibcode:2023PLoSO..1892922O. doi:10.1371/journal.pone.0292922. ISSN 1932-6203. PMC 10581466. PMID 37847698.
Adams, Zachary W.; Marriott, Brigid R.; Hulvershorn, Leslie A.; Hinckley, Jesse (January 2023). "Treatment of Adolescent Cannabis Use Disorders". Child and Adolescent Psychiatric Clinics of North America. 32 (1): 141–155. doi:10.1016/j.chc.2022.07.006. ISSN 1558-0490. PMC 10097012. PMID 36410901.
"Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation". Obstetrics & Gynecology. 130 (4): e205 – e209. October 2017. doi:10.1097/AOG.0000000000002354. PMID 28937574.
Gunn, J K L; Rosales, C B; Center, K E; Nuñez, A; Gibson, S J; Christ, C; Ehiri, J E (2016). "Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis". BMJ Open. 6 (4): e009986. doi:10.1136/bmjopen-2015-009986. ISSN 2044-6055. PMC 4823436. PMID 27048634.
Metz, Torri D.; Stickrath, Elaine H. (December 2015). "Marijuana use in pregnancy and lactation: a review of the evidence". American Journal of Obstetrics and Gynecology. 213 (6): 761–778. doi:10.1016/j.ajog.2015.05.025. ISSN 0002-9378. PMID 25986032.
Brown, R.A.; Dakkak, H.; Seabrook, J.A. (21 December 2018). "Is Breast Best? Examining the effects of alcohol and cannabis use during lactation". Journal of Neonatal-Perinatal Medicine. 11 (4): 345–356. doi:10.3233/npm-17125. ISSN 1934-5798. PMID 29843260. S2CID 44153511.
Seabrook, J.A.; Biden, C.; Campbell, E. (2017). "Does the risk of exposure to marijuana outweigh the benefits of breastfeeding? A systematic review". Canadian Journal of Midwifery Research and Practice. 16 (2): 8–16. doi:10.22374/cjmrp.v16i2.67.
Roncero, Carlos; Valriberas-Herrero, Isabel; Mezzatesta-Gava, Marcela; Villegas, José L.; Aguilar, Lourdes; Grau-López, Lara (17 February 2020). "Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review". Reproductive Health. 17 (1): 25. doi:10.1186/s12978-020-0880-9. ISSN 1742-4755. PMC 7027300. PMID 32066469.
Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, et al. (August 2013). "DSM-5 criteria for substance use disorders: recommendations and rationale". The American Journal of Psychiatry. 170 (8): 834–51. doi:10.1176/appi.ajp.2013.12060782. PMC 3767415. PMID 23903334.
Murrie, Benjamin; Lappin, Julia; Large, Matthew; Sara, Grant (16 October 2019). "Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis". Schizophrenia Bulletin. 46 (3): 505–516. doi:10.1093/schbul/sbz102. PMC 7147575. PMID 31618428.
Casajuana, Cristina; López-Pelayo, Hugo; Balcells, María Mercedes; Miquel, Laia; Colom, Joan; Gual, Antoni (2016). "Definitions of Risky and Problematic Cannabis Use: A Systematic Review". Substance Use & Misuse. 51 (13): 1760–1770. doi:10.1080/10826084.2016.1197266. ISSN 1532-2491. PMID 27556867. S2CID 32299878.
López-Pelayo, H.; Batalla, A.; Balcells, M. M.; Colom, J.; Gual, A. (2015). "Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments". Psychological Medicine. 45 (6): 1121–1133. doi:10.1017/S0033291714002463. ISSN 1469-8978. PMID 25366671. S2CID 206254638.
Copeland J, Swift W (April 2009). "Cannabis use disorder: epidemiology and management". International Review of Psychiatry (Review). 21 (2): 96–103. doi:10.1080/09540260902782745. PMID 19367503. S2CID 10881676.
Gates, Peter J.; Sabioni, Pamela; Copeland, Jan; Le Foll, Bernard; Gowing, Linda (5 May 2016). "Psychosocial interventions for cannabis use disorder". The Cochrane Database of Systematic Reviews. 2016 (5): CD005336. doi:10.1002/14651858.CD005336.pub4. ISSN 1469-493X. PMC 4914383. PMID 27149547.
Sussman, Steve (1010). "A Review of Alcoholics Anonymous/Narcotics Anonymous Programs for Teens". Evaluation & the Health Professions. 33 (1): 26–55. doi:10.1177/0163278709356186. PMC 4181564. PMID 20164105.
Zehra A, Burns J, Liu CK, Manza P, Wiers CE, Volkow ND, Wang GJ (December 2018). "Cannabis Addiction and the Brain: a Review". Journal of Neuroimmune Pharmacology. 13 (4): 438–452. doi:10.1007/s11481-018-9782-9. PMC 6223748. PMID 29556883.
Brezing CA, Levin FR (January 2018). "The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal". Neuropsychopharmacology. 43 (1): 173–194. doi:10.1038/npp.2017.212. PMC 5719115. PMID 28875989.
Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J (2018). "Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review" (PDF). Psychotherapy and Psychosomatics. 87 (4): 195–203. doi:10.1159/000491524. PMID 30016772. S2CID 51677365.
Sabioni, Pamela; Le Foll, Bernard (2018). "Psychosocial and pharmacological interventions for the treatment of cannabis use disorder". F1000Research. 7: 173. doi:10.12688/f1000research.11191.1. ISSN 2046-1402. PMC 5811668. PMID 29497498.
Treloar C, Holt M (2006). "Deficit models and divergent philosophies: Service providers' perspectives on barriers and incentives to drug treatment". Drugs: Education Prevention and Policy. 13 (4): 367–382. doi:10.1080/09687630600761444. S2CID 73095850.
Gates P, Taplin S, Copeland J, Swift W, Martin G (2008). "Barriers and Facilitators to Cannabis Treatment". Drug and Alcohol Review. 31 (3). National Cannabis Prevention and Information Centre, University of New South Wales, Sydney: 311–9. doi:10.1111/j.1465-3362.2011.00313.x. PMID 21521384.
Fischer, Benedikt; Russell, Cayley; Sabioni, Pamela; van den Brink, Wim; Le Foll, Bernard; Hall, Wayne; Rehm, Jürgen; Room, Robin (August 2017). "Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations". American Journal of Public Health. 107 (8): e1 – e12. doi:10.2105/AJPH.2017.303818. ISSN 0090-0036. PMC 5508136. PMID 28644037.
Marshall K, Gowing L, Ali R, Le Foll B (17 December 2014). "Pharmacotherapies for cannabis dependence". The Cochrane Database of Systematic Reviews. 12 (12): CD008940. doi:10.1002/14651858.CD008940.pub2. PMC 4297244. PMID 25515775.
Degenhardt L, Charlson F, Ferrari A, Santomauro D, Erskine H, Mantilla-Herrara A, et al. (GBD 2016 Alcohol and Drug Use Collaborators) (December 2018). "The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016". The Lancet. Psychiatry. 5 (12): 987–1012. doi:10.1016/S2215-0366(18)30337-7. PMC 6251968. PMID 30392731.
Scott, JC; Slomiak, ST; Jones, JD; Rosen, AFG; Moore, TM; Gur, RC (1 June 2018). "Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis". JAMA Psychiatry. 75 (6): 585–595. doi:10.1001/jamapsychiatry.2018.0335. PMC 6137521. PMID 29710074.

drugabuse.gov

National Institute on Drug Abuse (2014), The Science of Drug Abuse and Addiction: The Basics, archived from the original on 1 April 2022, retrieved 17 March 2016
Robertson, E.B. "Information on Cannabis Addiction". National Institute on Drug Abuse. Archived from the original on 7 May 2018. Retrieved 7 May 2018.
"DrugFacts: Marijuana". National Institute on Drug Abuse. Retrieved 20 July 2015.

dsm5.org

"Proposed Revision | APA DSM-5". Dsm5.org. Retrieved 20 April 2011.

espad.org

"Summary | www.espad.org". espad.org. Retrieved 5 February 2019.

europa.eu

emcdda.europa.eu

"Statistical Bulletin 2018 — prevalence of drug use | www.emcdda.europa.eu". emcdda.europa.eu. Retrieved 5 February 2019.

gouv.qc.ca

cisss-lanaudiere.gouv.qc.ca

LEMIRE, L. (2014). Enquête québécoise sur la santé des jeunes du secondaire 2010-2011. Santé publique. Récupéré de http://www.cisss-lanaudiere.gouv.qc.ca/fileadmin/internet/cisss_lanaudiere/Documentation/Sante_publique/Themes/Sante_mentale_et_psychosociale/EQSJS-Envir_social-Amis-VF.pdf

harvard.edu

ui.adsabs.harvard.edu

Madras BK (August 2014). "Dopamine challenge reveals neuroadaptive changes in marijuana abusers". Proceedings of the National Academy of Sciences of the United States of America. 111 (33): 11915–6. Bibcode:2014PNAS..11111915M. doi:10.1073/pnas.1412314111. PMC 4143049. PMID 25114244.
Oladunjoye, Adeolu Funso; Li, Elijah; Aneni, Kammarauche; Onigu-Otite, Edore (2023). "Cannabis use disorder, suicide attempts, and self-harm among adolescents: A national inpatient study across the United States". PLOS ONE. 18 (10): e0292922. Bibcode:2023PLoSO..1892922O. doi:10.1371/journal.pone.0292922. ISSN 1932-6203. PMC 10581466. PMID 37847698.

jaacap.org

Levine, Amir; Clemenza, Kelly; Rynn, Moira; Lieberman, Jeffrey (1 March 2017). "Evidence for the Risks and Consequences of Adolescent Cannabis Exposure". Journal of the American Academy of Child & Adolescent Psychiatry. 56 (3): 214–225. doi:10.1016/j.jaac.2016.12.014. ISSN 0890-8567. PMID 28219487.

nice.org.uk

pathways.nice.org.uk

"Generalised anxiety disorder – NICE Pathways". pathways.nice.org.uk. NICE. Archived from the original on 29 March 2019. Retrieved 13 April 2019.

nih.gov

pubmed.ncbi.nlm.nih.gov

Jacobus, Joanna; Goldenberg, Diane; Wierenga, Christina E.; Tolentino, Neil J.; Liu, Thomas T.; Tapert, Susan F. (1 August 2012). "Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users". Psychopharmacology. 222 (4): 675–684. doi:10.1007/s00213-012-2674-4. ISSN 1432-2072. PMC 3510003. PMID 22395430.
Gordon AJ, Conley JW, Gordon JM (December 2013). "Medical consequences of marijuana use: a review of current literature". Current Psychiatry Reports (Review). 15 (12): 419. doi:10.1007/s11920-013-0419-7. PMID 24234874. S2CID 29063282.
MacDonald, Kai (1 April 2016). "Why Not Pot?: A Review of the Brain-based Risks of Cannabis". Innovations in Clinical Neuroscience. 13 (3–4): 13–22. PMC 4911936. PMID 27354924.
Nielsen S, Gowing L, Sabioni P, Le Foll B (January 2019). "Pharmacotherapies for cannabis dependence". The Cochrane Database of Systematic Reviews. 1 (3): CD008940. doi:10.1002/14651858.CD008940.pub3. PMC 6360924. PMID 30687936.
Danovitch I, Gorelick DA (June 2012). "State of the art treatments for cannabis dependence". The Psychiatric Clinics of North America (Review). 35 (2): 309–26. doi:10.1016/j.psc.2012.03.003. PMC 3371269. PMID 22640758.
Dervaux A, Laqueille X (December 2012). "[Cannabis: Use and dependence]". Presse Médicale (in French). 41 (12 Pt 1): 1233–40. doi:10.1016/j.lpm.2012.07.016. PMID 23040955.
Hirvonen J, Goodwin RS, Li CT, Terry GE, Zoghbi SS, Morse C, et al. (June 2012). "Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers". Molecular Psychiatry. 17 (6): 642–9. doi:10.1038/mp.2011.82. PMC 3223558. PMID 21747398.
Madras BK (August 2014). "Dopamine challenge reveals neuroadaptive changes in marijuana abusers". Proceedings of the National Academy of Sciences of the United States of America. 111 (33): 11915–6. Bibcode:2014PNAS..11111915M. doi:10.1073/pnas.1412314111. PMC 4143049. PMID 25114244.
González S, Cebeira M, Fernández-Ruiz J (June 2005). "Cannabinoid tolerance and dependence: a review of studies in laboratory animals". Pharmacology, Biochemistry, and Behavior. 81 (2): 300–18. doi:10.1016/j.pbb.2005.01.028. PMID 15919107. S2CID 23328509.
Maldonado R, Berrendero F, Ozaita A, Robledo P (May 2011). "Neurochemical basis of cannabis addiction". Neuroscience. 181: 1–17. doi:10.1016/j.neuroscience.2011.02.035. PMID 21334423. S2CID 6660057.
Wilkie G, Sakr B, Rizack T (May 2016). "Medical Marijuana Use in Oncology: A Review". JAMA Oncology. 2 (5): 670–675. doi:10.1001/jamaoncol.2016.0155. PMID 26986677.
Budney AJ, Roffman R, Stephens RS, Walker D (December 2007). "Marijuana dependence and its treatment". Addiction Science & Clinical Practice. 4 (1): 4–16. doi:10.1151/ascp07414 (inactive 15 April 2025). PMC 2797098. PMID 18292704.{{cite journal}}: CS1 maint: DOI inactive as of April 2025 (link)
Borgelt LM, Franson KL, Nussbaum AM, Wang GS (February 2013). "The pharmacologic and clinical effects of medical cannabis". Pharmacotherapy (Review). 33 (2): 195–209. doi:10.1002/phar.1187. PMID 23386598. S2CID 8503107.
Bahji, Anees; Stephenson, Callum; Tyo, Richard; Hawken, Emily R.; Seitz, Dallas P. (9 April 2020). "Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids". JAMA Network Open. 3 (4): e202370. doi:10.1001/jamanetworkopen.2020.2370. PMC 7146100. PMID 32271390.
Livne O, Shmulewitz D, Lev-Ran S, Hasin DS (February 2019). "DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults". Drug and Alcohol Dependence. 195: 170–177. doi:10.1016/j.drugalcdep.2018.09.005. PMC 6359953. PMID 30361043.
Allsop, David (2011). "The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress". Drug and Alcohol Dependence. 119 (1–2): 123–129. doi:10.1016/j.drugalcdep.2011.06.003. PMID 21724338. Retrieved 12 March 2024.
Cougle, Jesse R.; Hakes, Jahn K.; Macatee, Richard J.; Zvolensky, Michael J.; Chavarria, Jesus (27 April 2016). "Probability and Correlates of Dependence Among Regular Users of Alcohol, Nicotine, Cannabis, and Cocaine: Concurrent and Prospective Analyses of the National Epidemiologic Survey on Alcohol and Related Conditions". The Journal of Clinical Psychiatry. 77 (4): e444 – e450. doi:10.4088/JCP.14m09469. PMID 27137428.
Connor, Jason P.; Stjepanović, Daniel; Le Foll, Bernard; Hoch, Eva; Budney, Alan J.; Hall, Wayne D. (25 February 2021). "Cannabis use and cannabis use disorder". Nature Reviews Disease Primers. 7 (1): 3. doi:10.1038/s41572-021-00247-4. ISSN 2056-676X. PMC 8655458. PMID 33627670.
Gorelick, David A. (14 December 2023). "Cannabis-Related Disorders and Toxic Effects". New England Journal of Medicine. 389 (24): 2267–2275. doi:10.1056/NEJMra2212152. PMID 38091532.
Volkow, Nora D.; Swanson, James M.; Evins, A. Eden; DeLisi, Lynn E.; Meier, Madeline H.; Gonzalez, Raul; Bloomfield, Michael A. P.; Curran, H. Valerie; Baler, Ruben (1 March 2016). "Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review" (PDF). JAMA Psychiatry. 73 (3): 292–7. doi:10.1001/jamapsychiatry.2015.3278. ISSN 2168-622X. PMID 26842658.
Levine, Amir; Clemenza, Kelly; Rynn, Moira; Lieberman, Jeffrey (1 March 2017). "Evidence for the Risks and Consequences of Adolescent Cannabis Exposure". Journal of the American Academy of Child & Adolescent Psychiatry. 56 (3): 214–225. doi:10.1016/j.jaac.2016.12.014. ISSN 0890-8567. PMID 28219487.
Oladunjoye, Adeolu Funso; Li, Elijah; Aneni, Kammarauche; Onigu-Otite, Edore (2023). "Cannabis use disorder, suicide attempts, and self-harm among adolescents: A national inpatient study across the United States". PLOS ONE. 18 (10): e0292922. Bibcode:2023PLoSO..1892922O. doi:10.1371/journal.pone.0292922. ISSN 1932-6203. PMC 10581466. PMID 37847698.
Adams, Zachary W.; Marriott, Brigid R.; Hulvershorn, Leslie A.; Hinckley, Jesse (January 2023). "Treatment of Adolescent Cannabis Use Disorders". Child and Adolescent Psychiatric Clinics of North America. 32 (1): 141–155. doi:10.1016/j.chc.2022.07.006. ISSN 1558-0490. PMC 10097012. PMID 36410901.
"Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation". Obstetrics & Gynecology. 130 (4): e205 – e209. October 2017. doi:10.1097/AOG.0000000000002354. PMID 28937574.
Gunn, J K L; Rosales, C B; Center, K E; Nuñez, A; Gibson, S J; Christ, C; Ehiri, J E (2016). "Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis". BMJ Open. 6 (4): e009986. doi:10.1136/bmjopen-2015-009986. ISSN 2044-6055. PMC 4823436. PMID 27048634.
Metz, Torri D.; Stickrath, Elaine H. (December 2015). "Marijuana use in pregnancy and lactation: a review of the evidence". American Journal of Obstetrics and Gynecology. 213 (6): 761–778. doi:10.1016/j.ajog.2015.05.025. ISSN 0002-9378. PMID 25986032.
Brown, R.A.; Dakkak, H.; Seabrook, J.A. (21 December 2018). "Is Breast Best? Examining the effects of alcohol and cannabis use during lactation". Journal of Neonatal-Perinatal Medicine. 11 (4): 345–356. doi:10.3233/npm-17125. ISSN 1934-5798. PMID 29843260. S2CID 44153511.
Roncero, Carlos; Valriberas-Herrero, Isabel; Mezzatesta-Gava, Marcela; Villegas, José L.; Aguilar, Lourdes; Grau-López, Lara (17 February 2020). "Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review". Reproductive Health. 17 (1): 25. doi:10.1186/s12978-020-0880-9. ISSN 1742-4755. PMC 7027300. PMID 32066469.
Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, et al. (August 2013). "DSM-5 criteria for substance use disorders: recommendations and rationale". The American Journal of Psychiatry. 170 (8): 834–51. doi:10.1176/appi.ajp.2013.12060782. PMC 3767415. PMID 23903334.
Murrie, Benjamin; Lappin, Julia; Large, Matthew; Sara, Grant (16 October 2019). "Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis". Schizophrenia Bulletin. 46 (3): 505–516. doi:10.1093/schbul/sbz102. PMC 7147575. PMID 31618428.
Casajuana, Cristina; López-Pelayo, Hugo; Balcells, María Mercedes; Miquel, Laia; Colom, Joan; Gual, Antoni (2016). "Definitions of Risky and Problematic Cannabis Use: A Systematic Review". Substance Use & Misuse. 51 (13): 1760–1770. doi:10.1080/10826084.2016.1197266. ISSN 1532-2491. PMID 27556867. S2CID 32299878.
López-Pelayo, H.; Batalla, A.; Balcells, M. M.; Colom, J.; Gual, A. (2015). "Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments". Psychological Medicine. 45 (6): 1121–1133. doi:10.1017/S0033291714002463. ISSN 1469-8978. PMID 25366671. S2CID 206254638.
Copeland J, Swift W (April 2009). "Cannabis use disorder: epidemiology and management". International Review of Psychiatry (Review). 21 (2): 96–103. doi:10.1080/09540260902782745. PMID 19367503. S2CID 10881676.
Gates, Peter J.; Sabioni, Pamela; Copeland, Jan; Le Foll, Bernard; Gowing, Linda (5 May 2016). "Psychosocial interventions for cannabis use disorder". The Cochrane Database of Systematic Reviews. 2016 (5): CD005336. doi:10.1002/14651858.CD005336.pub4. ISSN 1469-493X. PMC 4914383. PMID 27149547.
Sussman, Steve (1010). "A Review of Alcoholics Anonymous/Narcotics Anonymous Programs for Teens". Evaluation & the Health Professions. 33 (1): 26–55. doi:10.1177/0163278709356186. PMC 4181564. PMID 20164105.
Zehra A, Burns J, Liu CK, Manza P, Wiers CE, Volkow ND, Wang GJ (December 2018). "Cannabis Addiction and the Brain: a Review". Journal of Neuroimmune Pharmacology. 13 (4): 438–452. doi:10.1007/s11481-018-9782-9. PMC 6223748. PMID 29556883.
Brezing CA, Levin FR (January 2018). "The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal". Neuropsychopharmacology. 43 (1): 173–194. doi:10.1038/npp.2017.212. PMC 5719115. PMID 28875989.
Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J (2018). "Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review" (PDF). Psychotherapy and Psychosomatics. 87 (4): 195–203. doi:10.1159/000491524. PMID 30016772. S2CID 51677365.
Sabioni, Pamela; Le Foll, Bernard (2018). "Psychosocial and pharmacological interventions for the treatment of cannabis use disorder". F1000Research. 7: 173. doi:10.12688/f1000research.11191.1. ISSN 2046-1402. PMC 5811668. PMID 29497498.
Gates P, Taplin S, Copeland J, Swift W, Martin G (2008). "Barriers and Facilitators to Cannabis Treatment". Drug and Alcohol Review. 31 (3). National Cannabis Prevention and Information Centre, University of New South Wales, Sydney: 311–9. doi:10.1111/j.1465-3362.2011.00313.x. PMID 21521384.
Fischer, Benedikt; Russell, Cayley; Sabioni, Pamela; van den Brink, Wim; Le Foll, Bernard; Hall, Wayne; Rehm, Jürgen; Room, Robin (August 2017). "Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations". American Journal of Public Health. 107 (8): e1 – e12. doi:10.2105/AJPH.2017.303818. ISSN 0090-0036. PMC 5508136. PMID 28644037.
Marshall K, Gowing L, Ali R, Le Foll B (17 December 2014). "Pharmacotherapies for cannabis dependence". The Cochrane Database of Systematic Reviews. 12 (12): CD008940. doi:10.1002/14651858.CD008940.pub2. PMC 4297244. PMID 25515775.
Degenhardt L, Charlson F, Ferrari A, Santomauro D, Erskine H, Mantilla-Herrara A, et al. (GBD 2016 Alcohol and Drug Use Collaborators) (December 2018). "The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016". The Lancet. Psychiatry. 5 (12): 987–1012. doi:10.1016/S2215-0366(18)30337-7. PMC 6251968. PMID 30392731.
Scott, JC; Slomiak, ST; Jones, JD; Rosen, AFG; Moore, TM; Gur, RC (1 June 2018). "Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis". JAMA Psychiatry. 75 (6): 585–595. doi:10.1001/jamapsychiatry.2018.0335. PMC 6137521. PMID 29710074.

ncbi.nlm.nih.gov

Jacobus, Joanna; Goldenberg, Diane; Wierenga, Christina E.; Tolentino, Neil J.; Liu, Thomas T.; Tapert, Susan F. (1 August 2012). "Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users". Psychopharmacology. 222 (4): 675–684. doi:10.1007/s00213-012-2674-4. ISSN 1432-2072. PMC 3510003. PMID 22395430.
MacDonald, Kai (1 April 2016). "Why Not Pot?: A Review of the Brain-based Risks of Cannabis". Innovations in Clinical Neuroscience. 13 (3–4): 13–22. PMC 4911936. PMID 27354924.
Nielsen S, Gowing L, Sabioni P, Le Foll B (January 2019). "Pharmacotherapies for cannabis dependence". The Cochrane Database of Systematic Reviews. 1 (3): CD008940. doi:10.1002/14651858.CD008940.pub3. PMC 6360924. PMID 30687936.
Danovitch I, Gorelick DA (June 2012). "State of the art treatments for cannabis dependence". The Psychiatric Clinics of North America (Review). 35 (2): 309–26. doi:10.1016/j.psc.2012.03.003. PMC 3371269. PMID 22640758.
Hirvonen J, Goodwin RS, Li CT, Terry GE, Zoghbi SS, Morse C, et al. (June 2012). "Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers". Molecular Psychiatry. 17 (6): 642–9. doi:10.1038/mp.2011.82. PMC 3223558. PMID 21747398.
Madras BK (August 2014). "Dopamine challenge reveals neuroadaptive changes in marijuana abusers". Proceedings of the National Academy of Sciences of the United States of America. 111 (33): 11915–6. Bibcode:2014PNAS..11111915M. doi:10.1073/pnas.1412314111. PMC 4143049. PMID 25114244.
Budney AJ, Roffman R, Stephens RS, Walker D (December 2007). "Marijuana dependence and its treatment". Addiction Science & Clinical Practice. 4 (1): 4–16. doi:10.1151/ascp07414 (inactive 15 April 2025). PMC 2797098. PMID 18292704.{{cite journal}}: CS1 maint: DOI inactive as of April 2025 (link)
Bahji, Anees; Stephenson, Callum; Tyo, Richard; Hawken, Emily R.; Seitz, Dallas P. (9 April 2020). "Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids". JAMA Network Open. 3 (4): e202370. doi:10.1001/jamanetworkopen.2020.2370. PMC 7146100. PMID 32271390.
Livne O, Shmulewitz D, Lev-Ran S, Hasin DS (February 2019). "DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults". Drug and Alcohol Dependence. 195: 170–177. doi:10.1016/j.drugalcdep.2018.09.005. PMC 6359953. PMID 30361043.
Connor, Jason P.; Stjepanović, Daniel; Le Foll, Bernard; Hoch, Eva; Budney, Alan J.; Hall, Wayne D. (25 February 2021). "Cannabis use and cannabis use disorder". Nature Reviews Disease Primers. 7 (1): 3. doi:10.1038/s41572-021-00247-4. ISSN 2056-676X. PMC 8655458. PMID 33627670.
Oladunjoye, Adeolu Funso; Li, Elijah; Aneni, Kammarauche; Onigu-Otite, Edore (2023). "Cannabis use disorder, suicide attempts, and self-harm among adolescents: A national inpatient study across the United States". PLOS ONE. 18 (10): e0292922. Bibcode:2023PLoSO..1892922O. doi:10.1371/journal.pone.0292922. ISSN 1932-6203. PMC 10581466. PMID 37847698.
Adams, Zachary W.; Marriott, Brigid R.; Hulvershorn, Leslie A.; Hinckley, Jesse (January 2023). "Treatment of Adolescent Cannabis Use Disorders". Child and Adolescent Psychiatric Clinics of North America. 32 (1): 141–155. doi:10.1016/j.chc.2022.07.006. ISSN 1558-0490. PMC 10097012. PMID 36410901.
Gunn, J K L; Rosales, C B; Center, K E; Nuñez, A; Gibson, S J; Christ, C; Ehiri, J E (2016). "Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis". BMJ Open. 6 (4): e009986. doi:10.1136/bmjopen-2015-009986. ISSN 2044-6055. PMC 4823436. PMID 27048634.
Roncero, Carlos; Valriberas-Herrero, Isabel; Mezzatesta-Gava, Marcela; Villegas, José L.; Aguilar, Lourdes; Grau-López, Lara (17 February 2020). "Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review". Reproductive Health. 17 (1): 25. doi:10.1186/s12978-020-0880-9. ISSN 1742-4755. PMC 7027300. PMID 32066469.
Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, et al. (August 2013). "DSM-5 criteria for substance use disorders: recommendations and rationale". The American Journal of Psychiatry. 170 (8): 834–51. doi:10.1176/appi.ajp.2013.12060782. PMC 3767415. PMID 23903334.
Murrie, Benjamin; Lappin, Julia; Large, Matthew; Sara, Grant (16 October 2019). "Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis". Schizophrenia Bulletin. 46 (3): 505–516. doi:10.1093/schbul/sbz102. PMC 7147575. PMID 31618428.
Gates, Peter J.; Sabioni, Pamela; Copeland, Jan; Le Foll, Bernard; Gowing, Linda (5 May 2016). "Psychosocial interventions for cannabis use disorder". The Cochrane Database of Systematic Reviews. 2016 (5): CD005336. doi:10.1002/14651858.CD005336.pub4. ISSN 1469-493X. PMC 4914383. PMID 27149547.
Sussman, Steve (1010). "A Review of Alcoholics Anonymous/Narcotics Anonymous Programs for Teens". Evaluation & the Health Professions. 33 (1): 26–55. doi:10.1177/0163278709356186. PMC 4181564. PMID 20164105.
Zehra A, Burns J, Liu CK, Manza P, Wiers CE, Volkow ND, Wang GJ (December 2018). "Cannabis Addiction and the Brain: a Review". Journal of Neuroimmune Pharmacology. 13 (4): 438–452. doi:10.1007/s11481-018-9782-9. PMC 6223748. PMID 29556883.
Brezing CA, Levin FR (January 2018). "The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal". Neuropsychopharmacology. 43 (1): 173–194. doi:10.1038/npp.2017.212. PMC 5719115. PMID 28875989.
Sabioni, Pamela; Le Foll, Bernard (2018). "Psychosocial and pharmacological interventions for the treatment of cannabis use disorder". F1000Research. 7: 173. doi:10.12688/f1000research.11191.1. ISSN 2046-1402. PMC 5811668. PMID 29497498.
Fischer, Benedikt; Russell, Cayley; Sabioni, Pamela; van den Brink, Wim; Le Foll, Bernard; Hall, Wayne; Rehm, Jürgen; Room, Robin (August 2017). "Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations". American Journal of Public Health. 107 (8): e1 – e12. doi:10.2105/AJPH.2017.303818. ISSN 0090-0036. PMC 5508136. PMID 28644037.
Marshall K, Gowing L, Ali R, Le Foll B (17 December 2014). "Pharmacotherapies for cannabis dependence". The Cochrane Database of Systematic Reviews. 12 (12): CD008940. doi:10.1002/14651858.CD008940.pub2. PMC 4297244. PMID 25515775.
Degenhardt L, Charlson F, Ferrari A, Santomauro D, Erskine H, Mantilla-Herrara A, et al. (GBD 2016 Alcohol and Drug Use Collaborators) (December 2018). "The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016". The Lancet. Psychiatry. 5 (12): 987–1012. doi:10.1016/S2215-0366(18)30337-7. PMC 6251968. PMID 30392731.
Scott, JC; Slomiak, ST; Jones, JD; Rosen, AFG; Moore, TM; Gur, RC (1 June 2018). "Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis". JAMA Psychiatry. 75 (6): 585–595. doi:10.1001/jamapsychiatry.2018.0335. PMC 6137521. PMID 29710074.

nih.gov

"Marijuana use disorder is common and often untreated". National Institutes of Health (NIH). 4 March 2016. Retrieved 3 April 2019.

pmc.ncbi.nlm.nih.gov

Adams, Zachary W.; Marriott, Brigid R.; Hulvershorn, Leslie A.; Hinckley, Jesse (January 2023). "Treatment of Adolescent Cannabis Use Disorders". Child and Adolescent Psychiatric Clinics of North America. 32 (1): 141–155. doi:10.1016/j.chc.2022.07.006. ISSN 1558-0490. PMC 10097012. PMID 36410901.

nytimes.com

Smith, Dana (10 April 2023). "How Do You Know if You're Addicted to Weed?". The New York Times. Retrieved 24 June 2024.

pewresearch.org

"6 facts about marijuana". 10 April 2024.

psychiatrist.com

"Maternal Cannabis Use During Pregnancy and Neuropsychiatric Adverse Outcomes During Childhood and Early Adult Life". Psychiatrist.com. Retrieved 6 March 2025.

rogershospital.org

"DSM-5 Now Categorizes Substance Use Disorder in a Single Continuum". American Psychiatric Association. 17 May 2013. Archived from the original on 7 February 2015. Retrieved 12 December 2013.

samhsa.gov

archive.samhsa.gov

"Treatment Episode Data Set (TEDS)2001 – 2011. National Admissions to Substance Abuse Treatment Services" (PDF). samhsa.gov. Substance Abuse and Mental Health Services Administration. Archived from the original (PDF) on 1 August 2017. Retrieved 17 April 2015.

sciencedirect.com

Allsop, David (2011). "The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress". Drug and Alcohol Dependence. 119 (1–2): 123–129. doi:10.1016/j.drugalcdep.2011.06.003. PMID 21724338. Retrieved 12 March 2024.

semanticscholar.org

api.semanticscholar.org

Gordon AJ, Conley JW, Gordon JM (December 2013). "Medical consequences of marijuana use: a review of current literature". Current Psychiatry Reports (Review). 15 (12): 419. doi:10.1007/s11920-013-0419-7. PMID 24234874. S2CID 29063282.
González S, Cebeira M, Fernández-Ruiz J (June 2005). "Cannabinoid tolerance and dependence: a review of studies in laboratory animals". Pharmacology, Biochemistry, and Behavior. 81 (2): 300–18. doi:10.1016/j.pbb.2005.01.028. PMID 15919107. S2CID 23328509.
Maldonado R, Berrendero F, Ozaita A, Robledo P (May 2011). "Neurochemical basis of cannabis addiction". Neuroscience. 181: 1–17. doi:10.1016/j.neuroscience.2011.02.035. PMID 21334423. S2CID 6660057.
Borgelt LM, Franson KL, Nussbaum AM, Wang GS (February 2013). "The pharmacologic and clinical effects of medical cannabis". Pharmacotherapy (Review). 33 (2): 195–209. doi:10.1002/phar.1187. PMID 23386598. S2CID 8503107.
Brown, R.A.; Dakkak, H.; Seabrook, J.A. (21 December 2018). "Is Breast Best? Examining the effects of alcohol and cannabis use during lactation". Journal of Neonatal-Perinatal Medicine. 11 (4): 345–356. doi:10.3233/npm-17125. ISSN 1934-5798. PMID 29843260. S2CID 44153511.
Casajuana, Cristina; López-Pelayo, Hugo; Balcells, María Mercedes; Miquel, Laia; Colom, Joan; Gual, Antoni (2016). "Definitions of Risky and Problematic Cannabis Use: A Systematic Review". Substance Use & Misuse. 51 (13): 1760–1770. doi:10.1080/10826084.2016.1197266. ISSN 1532-2491. PMID 27556867. S2CID 32299878.
López-Pelayo, H.; Batalla, A.; Balcells, M. M.; Colom, J.; Gual, A. (2015). "Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments". Psychological Medicine. 45 (6): 1121–1133. doi:10.1017/S0033291714002463. ISSN 1469-8978. PMID 25366671. S2CID 206254638.
Copeland J, Swift W (April 2009). "Cannabis use disorder: epidemiology and management". International Review of Psychiatry (Review). 21 (2): 96–103. doi:10.1080/09540260902782745. PMID 19367503. S2CID 10881676.
Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J (2018). "Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review" (PDF). Psychotherapy and Psychosomatics. 87 (4): 195–203. doi:10.1159/000491524. PMID 30016772. S2CID 51677365.
Treloar C, Holt M (2006). "Deficit models and divergent philosophies: Service providers' perspectives on barriers and incentives to drug treatment". Drugs: Education Prevention and Policy. 13 (4): 367–382. doi:10.1080/09687630600761444. S2CID 73095850.

ucl.ac.uk

discovery.ucl.ac.uk

Volkow, Nora D.; Swanson, James M.; Evins, A. Eden; DeLisi, Lynn E.; Meier, Madeline H.; Gonzalez, Raul; Bloomfield, Michael A. P.; Curran, H. Valerie; Baler, Ruben (1 March 2016). "Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review" (PDF). JAMA Psychiatry. 73 (3): 292–7. doi:10.1001/jamapsychiatry.2015.3278. ISSN 2168-622X. PMID 26842658.

unifi.it

flore.unifi.it

Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J (2018). "Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review" (PDF). Psychotherapy and Psychosomatics. 87 (4): 195–203. doi:10.1159/000491524. PMID 30016772. S2CID 51677365.

unodc.org

"WDR 2022_Booklet 2". United Nations : Office on Drugs and Crime. Retrieved 7 November 2022.

web.archive.org

National Institute on Drug Abuse (2014), The Science of Drug Abuse and Addiction: The Basics, archived from the original on 1 April 2022, retrieved 17 March 2016
Robertson, E.B. "Information on Cannabis Addiction". National Institute on Drug Abuse. Archived from the original on 7 May 2018. Retrieved 7 May 2018.
"DSM-5 Now Categorizes Substance Use Disorder in a Single Continuum". American Psychiatric Association. 17 May 2013. Archived from the original on 7 February 2015. Retrieved 12 December 2013.
"Generalised anxiety disorder – NICE Pathways". pathways.nice.org.uk. NICE. Archived from the original on 29 March 2019. Retrieved 13 April 2019.
"Treatment Episode Data Set (TEDS)2001 – 2011. National Admissions to Substance Abuse Treatment Services" (PDF). samhsa.gov. Substance Abuse and Mental Health Services Administration. Archived from the original (PDF) on 1 August 2017. Retrieved 17 April 2015.
"Drug Info". Australian Drug Foundation. Archived from the original on 25 April 2011.

who.int

icd.who.int

"ICD-11 – Mortality and Morbidity Statistics". icd.who.int. Retrieved 17 November 2019.
"ICD-10 Version:2016". icd.who.int. Retrieved 17 November 2019.

worldcat.org

search.worldcat.org

Jacobus, Joanna; Goldenberg, Diane; Wierenga, Christina E.; Tolentino, Neil J.; Liu, Thomas T.; Tapert, Susan F. (1 August 2012). "Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users". Psychopharmacology. 222 (4): 675–684. doi:10.1007/s00213-012-2674-4. ISSN 1432-2072. PMC 3510003. PMID 22395430.
Connor, Jason P.; Stjepanović, Daniel; Le Foll, Bernard; Hoch, Eva; Budney, Alan J.; Hall, Wayne D. (25 February 2021). "Cannabis use and cannabis use disorder". Nature Reviews Disease Primers. 7 (1): 3. doi:10.1038/s41572-021-00247-4. ISSN 2056-676X. PMC 8655458. PMID 33627670.
Volkow, Nora D.; Swanson, James M.; Evins, A. Eden; DeLisi, Lynn E.; Meier, Madeline H.; Gonzalez, Raul; Bloomfield, Michael A. P.; Curran, H. Valerie; Baler, Ruben (1 March 2016). "Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review" (PDF). JAMA Psychiatry. 73 (3): 292–7. doi:10.1001/jamapsychiatry.2015.3278. ISSN 2168-622X. PMID 26842658.
Levine, Amir; Clemenza, Kelly; Rynn, Moira; Lieberman, Jeffrey (1 March 2017). "Evidence for the Risks and Consequences of Adolescent Cannabis Exposure". Journal of the American Academy of Child & Adolescent Psychiatry. 56 (3): 214–225. doi:10.1016/j.jaac.2016.12.014. ISSN 0890-8567. PMID 28219487.
National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on the Health Effects of Marijuana: an Evidence Review and Research Agenda. (2017). The health effects of cannabis and cannabinoids : the current state of evidence and recommendations for research. The National Academies Press. ISBN 978-0-309-45304-2. OCLC 1021254335.{{cite book}}: CS1 maint: multiple names: authors list (link)
Montoya, Ivan D.; Weiss, Susan R. B. (2018). Cannabis use disorders (1 ed.). New York, NY: Springer Berlin Heidelberg. ISBN 978-3-319-90364-4. OCLC 1029794724.
Oladunjoye, Adeolu Funso; Li, Elijah; Aneni, Kammarauche; Onigu-Otite, Edore (2023). "Cannabis use disorder, suicide attempts, and self-harm among adolescents: A national inpatient study across the United States". PLOS ONE. 18 (10): e0292922. Bibcode:2023PLoSO..1892922O. doi:10.1371/journal.pone.0292922. ISSN 1932-6203. PMC 10581466. PMID 37847698.
Adams, Zachary W.; Marriott, Brigid R.; Hulvershorn, Leslie A.; Hinckley, Jesse (January 2023). "Treatment of Adolescent Cannabis Use Disorders". Child and Adolescent Psychiatric Clinics of North America. 32 (1): 141–155. doi:10.1016/j.chc.2022.07.006. ISSN 1558-0490. PMC 10097012. PMID 36410901.
Gunn, J K L; Rosales, C B; Center, K E; Nuñez, A; Gibson, S J; Christ, C; Ehiri, J E (2016). "Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis". BMJ Open. 6 (4): e009986. doi:10.1136/bmjopen-2015-009986. ISSN 2044-6055. PMC 4823436. PMID 27048634.
Metz, Torri D.; Stickrath, Elaine H. (December 2015). "Marijuana use in pregnancy and lactation: a review of the evidence". American Journal of Obstetrics and Gynecology. 213 (6): 761–778. doi:10.1016/j.ajog.2015.05.025. ISSN 0002-9378. PMID 25986032.
Brown, R.A.; Dakkak, H.; Seabrook, J.A. (21 December 2018). "Is Breast Best? Examining the effects of alcohol and cannabis use during lactation". Journal of Neonatal-Perinatal Medicine. 11 (4): 345–356. doi:10.3233/npm-17125. ISSN 1934-5798. PMID 29843260. S2CID 44153511.
Roncero, Carlos; Valriberas-Herrero, Isabel; Mezzatesta-Gava, Marcela; Villegas, José L.; Aguilar, Lourdes; Grau-López, Lara (17 February 2020). "Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review". Reproductive Health. 17 (1): 25. doi:10.1186/s12978-020-0880-9. ISSN 1742-4755. PMC 7027300. PMID 32066469.
Casajuana, Cristina; López-Pelayo, Hugo; Balcells, María Mercedes; Miquel, Laia; Colom, Joan; Gual, Antoni (2016). "Definitions of Risky and Problematic Cannabis Use: A Systematic Review". Substance Use & Misuse. 51 (13): 1760–1770. doi:10.1080/10826084.2016.1197266. ISSN 1532-2491. PMID 27556867. S2CID 32299878.
López-Pelayo, H.; Batalla, A.; Balcells, M. M.; Colom, J.; Gual, A. (2015). "Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments". Psychological Medicine. 45 (6): 1121–1133. doi:10.1017/S0033291714002463. ISSN 1469-8978. PMID 25366671. S2CID 206254638.
Gates, Peter J.; Sabioni, Pamela; Copeland, Jan; Le Foll, Bernard; Gowing, Linda (5 May 2016). "Psychosocial interventions for cannabis use disorder". The Cochrane Database of Systematic Reviews. 2016 (5): CD005336. doi:10.1002/14651858.CD005336.pub4. ISSN 1469-493X. PMC 4914383. PMID 27149547.
Sabioni, Pamela; Le Foll, Bernard (2018). "Psychosocial and pharmacological interventions for the treatment of cannabis use disorder". F1000Research. 7: 173. doi:10.12688/f1000research.11191.1. ISSN 2046-1402. PMC 5811668. PMID 29497498.
Fischer, Benedikt; Russell, Cayley; Sabioni, Pamela; van den Brink, Wim; Le Foll, Bernard; Hall, Wayne; Rehm, Jürgen; Room, Robin (August 2017). "Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations". American Journal of Public Health. 107 (8): e1 – e12. doi:10.2105/AJPH.2017.303818. ISSN 0090-0036. PMC 5508136. PMID 28644037.

zenodo.org

Gordon AJ, Conley JW, Gordon JM (December 2013). "Medical consequences of marijuana use: a review of current literature". Current Psychiatry Reports (Review). 15 (12): 419. doi:10.1007/s11920-013-0419-7. PMID 24234874. S2CID 29063282.